Faculty of Medicine and Surgery, Sapienza University of Rome, 00185 Rome, Italy.
Geneva Foundation for Medical Education and Research, 1206 Geneva, Switzerland.
Int J Mol Sci. 2023 Oct 21;24(20):15420. doi: 10.3390/ijms242015420.
Today, there is strong and diversified evidence that in humans at least 50% of early embryos do not proceed beyond the pre-implantation period. This evidence comes from clinical investigations, demography, epidemiology, embryology, immunology, and molecular biology. The purpose of this article is to highlight the steps leading to the establishment of pregnancy and placenta formation. These early events document the existence of a clear distinction between embryonic losses during the first two weeks after conception and those occurring during the subsequent months. This review attempts to highlight the nature of the maternal-embryonic dialogue and the major mechanisms active during the pre-implantation period aimed at "selecting" embryos with the ability to proceed to the formation of the placenta and therefore to the completion of pregnancy. This intense molecular cross-talk between the early embryo and the endometrium starts even before the blastocyst reaches the uterine cavity, substantially initiating and conditioning the process of implantation and the formation of the placenta. Today, several factors involved in this dialogue have been identified, although the best-known and overall, the most important, still remains , indispensable during the first 8 to 10 weeks after fertilization. In addition, there are other substances acting during the first days following fertilization, the , believed to be involved in the suppression of the maternal response, thereby allowing the continued viability of the early embryo. The secreted between 2 and 4 days after fertilization. This linear peptide molecule exhibits a self-protective and antitoxic action, is present in maternal blood as early as 7 days after conception, and is absent in the presence of non-viable embryos. The , produced and released by embryos of all mammalian species studied seems to have a role in the ligand-mediated trophic support of the early embryo. The implantation process is also guided by signals from cells in the decidualized endometrium. Various types of cells are involved, among them epithelial, stromal, and trophoblastic, producing a number of cellular molecules, such as cytokines, chemokines, growth factors, and adhesion molecules. Immune cells are also involved, mainly uterine natural killer cells, macrophages, and T cells. In conclusion, events taking place during the first two weeks after fertilization determine whether pregnancy can proceed and therefore whether placenta's formation can proceed. These events represent the scientific basis for a clear distinction between the first two weeks following fertilization and the rest of gestation. For this reason, we propose that a new nomenclature be adopted specifically separating the two periods. In other words, the period from fertilization and birth should be named "gestation", whereas that from the completion of the process of implantation leading to the formation of the placenta, and birth should be named "pregnancy".
如今,有大量且多样化的证据表明,人类至少有 50%的早期胚胎无法进入着床前阶段。这些证据来自临床研究、人口统计学、流行病学、胚胎学、免疫学和分子生物学。本文旨在强调导致妊娠和胎盘形成的步骤。这些早期事件记录了受孕后两周内胚胎丢失与随后几个月内胚胎丢失之间的明显区别。本综述试图强调母体-胚胎对话的性质以及着床前阶段中活跃的主要机制,这些机制旨在“选择”具有继续形成胎盘能力的胚胎,从而完成妊娠。这种早期胚胎与子宫内膜之间的强烈分子相互作用甚至在囊胚到达子宫腔之前就已经开始,实质上启动并调节了着床和胎盘形成的过程。如今,已经确定了参与这种对话的几个因素,尽管众所周知且总体上最重要的因素仍然在受精后 8 到 10 周内不可或缺。此外,还有其他物质在受精后最初几天发挥作用,据信这些物质参与了母体反应的抑制,从而使早期胚胎能够继续存活。在受精后 2 到 4 天分泌。这种线性肽分子具有自我保护和解毒作用,在受孕后 7 天即可在母体血液中检测到,而在不存在有活力的胚胎时则不存在。这种由所有研究过的哺乳动物胚胎产生和释放的物质似乎在早期胚胎的配体介导的营养支持中发挥作用。着床过程也受到蜕膜化子宫内膜中细胞的信号引导。涉及多种类型的细胞,包括上皮细胞、基质细胞和滋养层细胞,它们产生许多细胞分子,如细胞因子、趋化因子、生长因子和粘附分子。免疫细胞也参与其中,主要是子宫自然杀伤细胞、巨噬细胞和 T 细胞。总之,受精后两周内发生的事件决定了妊娠是否能够继续,从而决定了胎盘的形成是否能够继续。这些事件为受精后两周内和妊娠其余部分之间的明确区分提供了科学依据。因此,我们建议采用一种新的命名法,专门将这两个时期分开。换句话说,从受精到出生的时期应命名为“妊娠”,而从着床过程完成到胎盘形成和出生的时期应命名为“怀孕”。